In HCC, there is increasing evidence demonstrating a correlation between EGFR overexpression and tumor aggressiveness, metastasis formation, therapy resistance, and poor prognosis of this disease [15, 20–22]. This evidence concerns the gene EGFR and hepatocellular carcinoma.